Business Description
Eurobio Scientific
ISIN : FR0013240934
Share Class Description:
XPAR:ALERS: Bearer and/or Registered shares issued from reverse splitCompare
Compare
Traded in other countries / regions
ALERS.FranceE8TN.GermanyDXNHF.USA IPO Date
2005-11-17Description
Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.88 | |||||
| Equity-to-Asset | 0.55 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 3.96 | |||||
| Interest Coverage | 2.33 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.94 | |||||
| Beneish M-Score | -3.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -11.5 | |||||
| 3-Year EBITDA Growth Rate | -33.9 | |||||
| 3-Year EPS without NRI Growth Rate | -57 | |||||
| 3-Year FCF Growth Rate | -24.3 | |||||
| 3-Year Book Growth Rate | 22.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 39.72 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 6.25 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.4 | |||||
| 9-Day RSI | 73.87 | |||||
| 14-Day RSI | 81.48 | |||||
| 6-1 Month Momentum % | 53.75 | |||||
| 12-1 Month Momentum % | 55.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.72 | |||||
| Quick Ratio | 2.32 | |||||
| Cash Ratio | 1.68 | |||||
| Days Inventory | 102.33 | |||||
| Days Sales Outstanding | 77.62 | |||||
| Days Payable | 56.59 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 4 | |||||
| Shareholder Yield % | -14.96 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 44 | |||||
| Operating Margin % | 7.76 | |||||
| Net Margin % | 3.7 | |||||
| FCF Margin % | 17.39 | |||||
| ROE % | 2.77 | |||||
| ROA % | 1.51 | |||||
| ROIC % | 3.13 | |||||
| 3-Year ROIIC % | -54.26 | |||||
| ROC (Joel Greenblatt) % | 34.48 | |||||
| ROCE % | 4.22 | |||||
| Years of Profitability over Past 10-Year | 5 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 51.99 | |||||
| Forward PE Ratio | 20.54 | |||||
| PE Ratio without NRI | 43.6 | |||||
| Shiller PE Ratio | 29.22 | |||||
| Price-to-Owner-Earnings | 11.94 | |||||
| PEG Ratio | 0.96 | |||||
| PS Ratio | 1.92 | |||||
| PB Ratio | 1.42 | |||||
| Price-to-Tangible-Book | 11.3 | |||||
| Price-to-Free-Cash-Flow | 11.05 | |||||
| Price-to-Operating-Cash-Flow | 9.39 | |||||
| EV-to-EBIT | 23.1 | |||||
| EV-to-EBITDA | 10.24 | |||||
| EV-to-Revenue | 2 | |||||
| EV-to-FCF | 11.53 | |||||
| Price-to-Projected-FCF | 0.53 | |||||
| Price-to-Median-PS-Value | 2.02 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.91 | |||||
| Price-to-Graham-Number | 4.68 | |||||
| Price-to-Net-Current-Asset-Value | 92.04 | |||||
| Earnings Yield (Greenblatt) % | 4.33 | |||||
| FCF Yield % | 9.1 | |||||
| Forward Rate of Return (Yacktman) % | 30.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Eurobio Scientific Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 130.646 | ||
| EPS (TTM) (€) | 0.478 | ||
| Beta | 0.41 | ||
| Volatility % | 50.4 | ||
| 14-Day RSI | 81.48 | ||
| 14-Day ATR (€) | 0.175985 | ||
| 20-Day SMA (€) | 24.765 | ||
| 12-1 Month Momentum % | 55.89 | ||
| 52-Week Range (€) | 12.2 - 25 | ||
| Shares Outstanding (Mil) | 10.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Eurobio Scientific Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Eurobio Scientific Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Eurobio Scientific Frequently Asked Questions
What is Eurobio Scientific(XPAR:ALERS)'s stock price today?
The current price of XPAR:ALERS is €24.85. The 52 week high of XPAR:ALERS is €25.00 and 52 week low is €12.20.
When is next earnings date of Eurobio Scientific(XPAR:ALERS)?
The next earnings date of Eurobio Scientific(XPAR:ALERS) is .
Does Eurobio Scientific(XPAR:ALERS) pay dividends? If so, how much?
Eurobio Scientific(XPAR:ALERS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers